Evaluating convalescent plasma therapy in severe COVID-19: a retrospective cohort study
CP therapy appears to be a safe and potentially effective treatment for severe COVID-19, especially in patients with certain baseline characteristics. These findings add valuable insights into the management of severe COVID-19 cases, although further research is needed to fully understand the implications and optimize treatment protocols.
Authors
- Hamid Reza Banafshe (ORCID: https://orcid.org/0000-0003-4450-8861)
- Reza Eshraghi (ORCID: https://orcid.org/0000-0003-3435-3851)
- Mário Taba (ORCID: https://orcid.org/0000-0002-7098-5090)
- Sayyed Alireza Moraveji
- Mojtaba Sehat (ORCID: https://orcid.org/0000-0001-7142-4829)
- Maryam Zare Tutestani
Institutions
- Kashan University of Medical Sciences (IR)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3855/jidc.19859
- Citations
- 3
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.17